CRISPR Interference (CRISPRi) for Targeted Gene Silencing in Mycobacteria
Authors:
- 8 July 2021
- book chapter
- Published by Springer Nature
- Vol. 2314, 343-364
Abstract
The genetic basis for Mycobacterium tuberculosis pathogenesis is incompletely understood. One reason for this knowledge gap is the relative difficulty of genetic manipulation of M. tuberculosis. To close this gap, we recently developed a robust CRISPR interference (CRISPRi) platform for programmable gene silencing in mycobacteria. In this chapter, we: (1) discuss some of the advantages and disadvantages of CRISPRi relative to more traditional genetic approaches; and (2) provide a protocol for the application of CRISPRi to reduce transcription of target genes in mycobacteria.Keywords
This publication has 27 references indexed in Scilit:
- Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas systemNucleic Acids Research, 2013
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- Global Assessment of Genomic Regions Required for Growth in Mycobacterium tuberculosisPLOS Pathogens, 2012
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequenceProceedings of the National Academy of Sciences, 2011
- Depletion of antibiotic targets has widely varying effects on growthProceedings of the National Academy of Sciences, 2011
- Protein inactivation in mycobacteria by controlled proteolysis and its application to deplete the beta subunit of RNA polymeraseNucleic Acids Research, 2010
- Short motif sequences determine the targets of the prokaryotic CRISPR defence systemMicrobiology, 2009
- Diversity, Activity, and Evolution of CRISPR Loci in Streptococcus thermophilusJournal of Bacteriology, 2008
- Phage Response to CRISPR-Encoded Resistance in Streptococcus thermophilusJournal of Bacteriology, 2008